MC
AGN

Metropolis Capital’s Allergan plc AGN Stock Holding History

Metropolis Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-183,597
Closed -$32.5M – 15
2020
Q1 		$32.5M Sell
183,597
-20,612
-10% -$3.88M 5.77% 8
2019
Q4 		$39M Buy
204,209
+33,649
+20% +$6.07M 5.42% 7
2019
Q3 		$28.7M Sell
170,560
-150,528
-47% -$24.5M 5.74% 7
2019
Q2 		$53.8M Buy
321,088
+94,220
+42% +$13M 12.32% 4
2019
Q1 		$33.2M Buy
226,868
+46,240
+26% +$6.7M 9.33% 6
2018
Q4 		$24.1M Buy
+180,628
New +$29.6M 9.04% 7

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Metropolis Capital's AGN Position: Q2 2020 in Review

Metropolis Capital sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 183,597 shares — an estimated $32.5M sold.

Metropolis Capital first reported a position in AGN in Q4 2018 and held it in 6 quarters. The position peaked at $53.8M in Q2 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Metropolis Capital reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Metropolis Capital sold 183,597 Allergan plc shares in Q2 2020, an estimated $32.5M.
  • Metropolis Capital first reported a position in Allergan plc in Q4 2018 and held it in 6 quarters.
  • Metropolis Capital's Allergan plc position peaked at $53.8M in Q2 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Metropolis Capital's 13F filing for Q2 2020, filed 6 Jul 2020.